Search - tctmd.com

Displaying 801 - 820 of 862

Sort: Relevancy | Date

News Daily News

PCI 死亡率公开与高危病例更少但结局更好相关

September 24, 2015

News Daily News

La Información Pública de la Mortalidad PCI se asoció a Menos Casos de Alto Riesgo pero a Mejore Resultados

September 24, 2015

Presentation

Collaborative Quality Improvement vs Public Reporting for PCI

Presenter: Thomas F. Boyden

September 23, 2015

News Industry News

Ventrix Initiates Clinical Trial of VentriGel™

September 17, 2015

News Conference News ESC 2015

UK Registry: No Relationship Between Hospital PCI Volume and Early Mortality

Yael L. Maxwell

September 01, 2015

News Industry News

New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN® (ezetimibe and simvastatin) and the TECOS Cardiovascular Safety Trial of JANUVIA® Will Be Presented at the European Society of Cardiology

August 20, 2015

Presentation

Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes

Presenter: BM. Everett BM

August 14, 2015

News Daily News

International Study Links Treatment Variations to Mortality in Acute MI

Yael L. Maxwell

August 14, 2015

News Daily News

BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival

Yael L. Maxwell

August 12, 2015

News Daily News

BARI 2D: El Mayor Control de los Factores de Riesgo en Pacientes con Diabetes Tipo 2 Mejora Supervivencia

Yael L. Maxwell

August 12, 2015

News Daily News

BARI 2D：改善 2 型糖尿病患者的危险因素控制情况可以提高其生存率

Yael L. Maxwell

August 12, 2015

Presentation

Comprehensive Cardiovascular Risk Factor Control Improves Survival: The BARI 2D Trial

Presenter: Vera Bittner

August 11, 2015

News Daily News

斑块消退证据对于联合使用他汀类药物与依泽替米贝的病例提出了支持

L.A. McKeown

July 29, 2015

News Daily News

La Evidencia de la Regresión de la Placa Avala el Uso Combinado de Ezetimibe+Estatinas

L.A. McKeown

July 29, 2015

News Industry News

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

July 29, 2015

News Daily News

Evidence of Plaque Regression Bolsters Case for Combining Ezetimibe With Statin

L.A. McKeown

July 29, 2015

News Features

医院、介入科医生有机会避免患者不必要的再次入院

July 28, 2015

News Features

Opportunities Exist for Hospitals, Interventionalists to Stave Off Unnecessary Readmissions

July 28, 2015

News Features

Hay Oportunidades para Hospitales e Intervencionistas que Eviten Rehospitalizaciones Innecesarias

July 28, 2015

News Industry News

Micell Technologies Announces First Patient Enrolled in Registration Trial of MiStent SES in China

July 22, 2015

Advertisement

PCI 死亡率公开与高危病例更少但结局更好相关

La Información Pública de la Mortalidad PCI se asoció a Menos Casos de Alto Riesgo pero a Mejore Resultados

Collaborative Quality Improvement vs Public Reporting for PCI

Ventrix Initiates Clinical Trial of VentriGel™

UK Registry: No Relationship Between Hospital PCI Volume and Early Mortality

New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN® (ezetimibe and simvastatin) and the TECOS Cardiovascular Safety Trial of JANUVIA® Will Be Presented at the European Society of Cardiology

Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes

International Study Links Treatment Variations to Mortality in Acute MI

BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival

BARI 2D: El Mayor Control de los Factores de Riesgo en Pacientes con Diabetes Tipo 2 Mejora Supervivencia

BARI 2D：改善 2 型糖尿病患者的危险因素控制情况可以提高其生存率

Comprehensive Cardiovascular Risk Factor Control Improves Survival: The BARI 2D Trial

斑块消退证据对于联合使用他汀类药物与依泽替米贝的病例提出了支持

La Evidencia de la Regresión de la Placa Avala el Uso Combinado de Ezetimibe+Estatinas

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

Evidence of Plaque Regression Bolsters Case for Combining Ezetimibe With Statin

医院、介入科医生有机会避免患者不必要的再次入院

Opportunities Exist for Hospitals, Interventionalists to Stave Off Unnecessary Readmissions

Hay Oportunidades para Hospitales e Intervencionistas que Eviten Rehospitalizaciones Innecesarias

Micell Technologies Announces First Patient Enrolled in Registration Trial of MiStent SES in China

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content